269.9500 3.63 (1.36%)
NSE Jun 02, 2025 15:31 PM
Volume: 361.2K
 

269.95
1.36%
BP Wealth
We expect a steady growth in earnings over the next couple of years (earnings CAGR of ~16.2% in FY19-21E versus ~13.1% (incl. amortization of goodwill) in FY13-19), which will aid to generate sizable cash flows. Apart from Niraparib, the visibility of new products has increased with 3 products filing from customers, which will not only accelerate growth, but also de-risk earnings from blockbuster products. The emerging signs of a recovery in Carbogen, bright prospects from Vitamin D business,...
Dishman Carbogen Amcis Ltd. is trading above all available SMAs
More from Dishman Carbogen Amcis Ltd.
Recommended